www.interpharma.co.th IP_OCS/010/2562 November 10, 2019 Subject Management’s discussion and analysis for the third quarter of 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited (“the

(Ending September 30, 2019) To Director and Manager of the Stock Exchange of Thailand Ubis (Asia) Public Company Limited (“the Company”) would like to clarify on the performance and the financial for Q3

, for example, the launch of Wealth Advice for All initiative which gives the public a more convenient access to one-stop services on investment advice and the co-launch of the Happy PVD Company project

The ASEAN Capital Markets Forum (ACMF) welcomed the progress achieved by the ASEAN Green Bond Standards at its meeting today. Since its launch in November 2017, the ASEAN Green Bond Standards have

No: AH 02022023 February 28th, 2023 Subject: Management Discussion & Analysis (MD&A) for the financial statements of fiscal year 2022 ended as of December 31, 2022 To: The President The Stock Exchange

1 27 May 2019 Subject: Explanation of operating result in the financial statement ended 31 March 2019 To: President of the Stock Exchange of Thailand With reference to the financial statement of FY

1 11 February 2019 Subject: Explanation of operating result in the financial statement ended 31 December 2018 To: President of the Stock Exchange of Thailand With reference to the financial statement

Attention: Directors and Manager, The Stock Exchange of Thailand N.D. Rubber Public Company Limited (“the Company”) would like to present the MD&A for the Three-Month period ended 30 September 2019 (3rd

, “Leadership Role and Sustainable Business,” and the launch of Gender Corner. The event aimed to raise awareness of women in leadership role and gender equality, and to recognise listed companies’ support for

Stock Exchange of Thailand Aapico Hitech Public Company Limited (“the Company”) would like to explain the consolidated financial statements of the Company for the 1st quarter of fiscal year 2023 ended as